What is the price target for CSTM stock?
10 analysts have analysed CSTM and the average price target is 29.58 USD. This implies a price increase of 19.95% is expected in the next year compared to the current price of 24.66.
NYSE:CSTM • FR0013467479
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONSTELLIUM SE (CSTM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-19 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-08 | Wells Fargo | Initiate | Equal-Weight |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-24 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-10 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-03 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-07-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-07-16 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-07-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-19 | Benchmark | Reiterate | Buy -> Buy |
| 2024-04-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-01-23 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-01-16 | UBS | Initiate | Buy |
| 2023-12-04 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | Benchmark | Maintains | Buy -> Buy |
| 2023-07-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.826B -3.62% | 7.335B -6.27% | 8.449B 15.19% | 10.261B 21.45% | 10.325B 0.62% | |
| EBITDA YoY % growth | 730M 15.32% | 575M -21.23% | 800M 39.13% | 839.33M 4.92% | 886.24M 5.59% | |
| EBIT YoY % growth | 430M 24.28% | 271M -36.98% | 470M 73.43% | 513.47M 9.25% | 557.98M 8.67% | |
| Operating Margin | 5.49% | 3.69% | 5.56% | 5.00% | 5.40% | |
| EPS YoY % growth | 0.85 -58.33% | 0.41 -51.65% | 1.62 293.74% | 2.05 26.85% | 2.40 16.73% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.60 141.58% | 0.56 153.85% | 0.40 13.46% | 0.35 -55.70% | 0.50 -16.24% | 0.52 -7.27% | 0.47 17.98% | 0.37 3.64% |
| Revenue Q2Q % growth | 2.581B 37.26% | 2.526B 36.17% | 2.245B 3.65% | 2.12B -3.68% | 2.512B -2.67% | 2.538B 0.48% | 2.436B 8.51% | 2.219B 4.67% |
| EBITDA Q2Q % growth | 227.38M 32.97% | 223.43M -6.90% | 185.57M -50.38% | 169.84M -65.83% | 206.04M -9.39% | 209.1M -6.41% | 199.92M 7.73% | 180.54M 6.30% |
| EBIT Q2Q % growth | 143.42M 54.22% | 138.11M 72.64% | 103.53M -20.36% | 88.23M -47.17% | 120.36M -16.08% | 124.44M -9.90% | 115.26M 11.33% | 95.88M 8.67% |
All data in USD
10 analysts have analysed CSTM and the average price target is 29.58 USD. This implies a price increase of 19.95% is expected in the next year compared to the current price of 24.66.
CONSTELLIUM SE (CSTM) will report earnings on 2026-04-28, before the market open.
The consensus EPS estimate for the next earnings of CONSTELLIUM SE (CSTM) is 0.6 USD and the consensus revenue estimate is 2.58B USD.
The consensus rating for CONSTELLIUM SE (CSTM) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.